business
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?
Key takeaways
- (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?
- (NASDAQ:CBLL) reported a study published in Critical Care Medicine that higher AI-detected seizure burden is linked with increased odds of disability results at discharge.
- The company said patients with a peak seizure burden of at least 90% were 3.4 times more likely to experience death or severe disability compared to those with no seizure burden.
Is Ceri Bell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy? Fatima Gulzar Sat, June 27, 2026 at 10:31 PM GMT+7 1 min read CBLL Ceri Bell, Inc. (NASDAQ:CBLL) is among the Best Brain-Computer Interface Stocks.
On June 8, Ceri Bell, Inc. (NASDAQ:CBLL) reported a study published in Critical Care Medicine that higher AI-detected seizure burden is linked with increased odds of disability results at discharge. It analyzed 359 adult patients across three academic centers.
The company said patients with a peak seizure burden of at least 90% were 3.4 times more likely to experience death or severe disability compared to those with no seizure burden. Hence, the elevated burden directly leads to poorer functional outcomes.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop